Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study ; volume:30 ; number:4 ; day:8 ; month:2 ; year:2023 ; pages:1642-1652 ; date:8.2023
Journal of nuclear cardiology ; 30, Heft 4 (8.2.2023), 1642-1652, 8.2023
- Creator
-
Boczar, Kevin E.
Beanlands, Rob S.
Glassman, Steven J.
Wang, Jerry
Zeng, Wanzhen
deKemp, Robert A.
Ward, Natalie C.
Fehlmann, Christophe A.
Wells, George A.
Karsh, Jacob
Dwivedi, Girish
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12350-023-03204-8
- URN
-
urn:nbn:de:101:1-2023102710131297808889
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boczar, Kevin E.
- Beanlands, Rob S.
- Glassman, Steven J.
- Wang, Jerry
- Zeng, Wanzhen
- deKemp, Robert A.
- Ward, Natalie C.
- Fehlmann, Christophe A.
- Wells, George A.
- Karsh, Jacob
- Dwivedi, Girish
- SpringerLink (Online service)
Other Objects (12)
Nicht-FDG-PET
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
FDG-PET in lymphoma
FDG-PET AND PET/CT-Part I
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
FDG-PET/CT in lymphoma
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
FDG PET/CT depicts cutaneous plasmocytoma
[18F]FDG PET/MRI in rectal cancer
18F-FDG PET/MRI in adult sarcomas
Nicht-FDG-PET
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
FDG-PET in lymphoma
FDG-PET AND PET/CT-Part I
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
FDG-PET/CT in lymphoma
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
FDG PET/CT depicts cutaneous plasmocytoma
[18F]FDG PET/MRI in rectal cancer
18F-FDG PET/MRI in adult sarcomas
Nicht-FDG-PET
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
FDG-PET in lymphoma
FDG-PET AND PET/CT-Part I
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
FDG-PET/CT in lymphoma
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
FDG PET/CT depicts cutaneous plasmocytoma
[18F]FDG PET/MRI in rectal cancer